Orion R&D

Orion’s pharmaceutical innovations are created within its R&D organisation. The organisation employs top professionals in the field of drug molecule development and optimisation.

Read more

Fighting cancer with the immune system – Orion launches an Immuno-Oncology drug discovery platform

Drug development goes remote

Orion R&D’s own strengths build the foundation for success

Orion Research Foundation grants for 2021 can be applied for between 1 August and 10 September 2020

Read more

Orion and Nanoform collaborate on next-generation drug development

Orion and Nanoform have announced a collaboration to apply Nanoform's  CESS® technology to new chemical entities.

Read more

Arrival of digital therapies to support patients and doctors

New publication in the Journal of Cardiovascular Pharmacology: Working hypothesis for mechanisms of action of levosimendan in patients with ALS

A Review article summarizing the Potential of Levosimendan in the Management of ALS: Overview of a Working Hypothesis

Read more

Outi Vaarala leads innovative work to save cancer patients

The goal of research into rare diseases is to find new and effective treatments

LEVALS study results assessing the effects of oral levosimendan in patients with ALS published

The Phase 2 clinical trial (LEVALS) show encouraging results: in 66 patients supine SVC was significantly higher after 14 days treatment on oral levosimendan compared to placebo.

Read more

Orion's R&D Pipeline

Research areas

Orion develops new pharmaceuticals in three therapy areas. Orion’s pharmaceutical R&D focuses on the central nervous system, cancer and critical care, and inhalable Easyhaler® pulmonary drugs. Orion also develops veterinary and generic drugs. 

Read more

Scientific publications

A list of recent posters presented at congresses and articles published in peer reviewed scientific journals.

Read more

Drug development

What does it take to develop a new medicine? To start with, you need a dedicated team of top scientists and other professionals. The journey might take up to fifteen years. Take a look!

Read more

Pharmaceutical R&D Ethics Policy

Our aim is to work in accordance with the requirements, standards and ethical codes of our industry in our pharmaceutical research and development activities too. Our R&D Policy highlights how we make sure that our practices are on an ethically sustainable basis. 

Read more

Partnering and licensing

Partnerships and networking are important for Orion throughout the entire value chain of operations. We collaborate with other companies in research and development, manufacturing and marketing of products internationally.

Read more